{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34056843",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/jdi.13605"
    ],
    "Journal": {
      "ISSN": "2040-1124",
      "JournalIssue": {
        "Volume": "12",
        "Issue": "7",
        "PubDate": {
          "Year": "2021",
          "Month": "Jul"
        }
      },
      "Title": "Journal of diabetes investigation",
      "ISOAbbreviation": "J Diabetes Investig"
    },
    "ArticleTitle": "The COVID-19 world - Are we there yet?",
    "Pagination": {
      "StartPage": "1125",
      "EndPage": "1127",
      "MedlinePgn": "1125-1127"
    },
    "Abstract": {
      "AbstractText": [
        "The spreading of SARS-CoV-2 virus infection is still of great concern as well as clinical and social interest. The key to conquer this pandemic would be establishment of herd immunity by vaccination and of treatment, and I have discussed issues we are facing now."
      ],
      "CopyrightInformation": "\u00a9 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-1938-7394"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kobe, Japan."
          },
          {
            "Identifier": [],
            "Affiliation": "Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan."
          }
        ],
        "LastName": "Hamamoto",
        "ForeName": "Yoshiyuki",
        "Initials": "Y"
      }
    ],
    "PublicationTypeList": [
      "Editorial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Japan",
    "MedlineTA": "J Diabetes Investig",
    "NlmUniqueID": "101520702",
    "ISSNLinking": "2040-1116"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunity, Herd"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "Y Hamamoto received speaker fees from Novo Nordisk Pharma Ltd and received a research grant from Sumitomo\u2010Dainippon Pharma Co., Ltd and Nippon Boehringer Ingelheim."
}